新股暗盤 | 深藍科技控股(1950.HK)暗盤段大漲逾20%
格隆匯3月11日丨據輝立證券,深藍科技控股(1950.HK)暗盤段現報0.63港元,較發行價0.52港元漲21.1%。公司是一家人工革化學品製造商,主要從事知名品牌“深藍科技”下的塗飾劑及合成樹脂的研發、製造及銷售。2016年至2018年收益分別為1.51億、1.57億、1.67億元人民幣,溢利分別為2540.6萬、3495萬、3079萬元人民幣,2018歷史市盈率14.63 - 17.56倍。公司此次發售2.5億股,其中香港公開發售2500萬股,國際發售2.25億股,每手4000股,淨籌8470萬港元;香港公開發售獲12.47倍認購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.